ConductScience.org, home
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
API referenceFor AI assistants

Trial · NCT01294683

Adverse events124

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 124

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherPruritusSkin and subcutaneous tissue disordersSequence 1: MK-0524B 2g/40g4248651
otherPruritusSkin and subcutaneous tissue disordersSequence 2: MK-0524A 2g + Simvastatin 40 mg3348638
otherPruritusSkin and subcutaneous tissue disordersSequence 1: MK-0524A 2g + Simvastatin 40 mg02300
otherPruritusSkin and subcutaneous tissue disordersSequence 2: MK-0524B 2g/40g02200
otherFlushingVascular disordersSequence 1: MK-0524B 2g/40g88486104
otherFlushingVascular disordersSequence 2: MK-0524A 2g + Simvastatin 40 mg7548686
otherFlushingVascular disordersSequence 1: MK-0524A 2g + Simvastatin 40 mg02300
otherFlushingVascular disordersSequence 2: MK-0524B 2g/40g02200
seriousCoronary artery diseaseCardiac disordersSequence 1: MK-0524B 2g/40g0486
seriousCoronary artery diseaseCardiac disordersSequence 2: MK-0524A 2g + Simvastatin 40 mg0486
seriousCoronary artery diseaseCardiac disordersSequence 1: MK-0524A 2g + Simvastatin 40 mg0230
seriousCoronary artery diseaseCardiac disordersSequence 2: MK-0524B 2g/40g1220
seriousGastrooesophageal reflux diseaseGastrointestinal disordersSequence 1: MK-0524B 2g/40g0486
seriousGastrooesophageal reflux diseaseGastrointestinal disordersSequence 2: MK-0524A 2g + Simvastatin 40 mg0486
seriousGastrooesophageal reflux diseaseGastrointestinal disordersSequence 1: MK-0524A 2g + Simvastatin 40 mg0230
seriousGastrooesophageal reflux diseaseGastrointestinal disordersSequence 2: MK-0524B 2g/40g1220
seriousDiverticulitisInfections and infestationsSequence 1: MK-0524B 2g/40g0486
seriousDiverticulitisInfections and infestationsSequence 2: MK-0524A 2g + Simvastatin 40 mg0486
seriousDiverticulitisInfections and infestationsSequence 1: MK-0524A 2g + Simvastatin 40 mg0230
seriousDiverticulitisInfections and infestationsSequence 2: MK-0524B 2g/40g1220

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01294683/events

API referenceFor AI assistants